Streetbeat News

Stock Prices

EOG

EOG Resources (NYSE:EOG) has seen a 3.48% increase in short interest since its last report, with 6.87 million shares sold short, representing 1.19% of its float. The short interest indicates market sentiment and takes 2.22 days on average to cover. Despite the increase, EOG's short interest is below its peer group average of 6.49%. This rise in short interest doesn't necessarily predict a price drop but indicates heightened short selling activity.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 3:15 pm

BKR

Baker Hughes (NYSE:BKR) has seen a 10.38% increase in its short percent of float, now at 3.19% with 21.10 million shares sold short. This indicates a bearish market sentiment, although it's lower than its peer group average of 9.38%. The rise in short interest suggests investors should be cautious, but it doesn't necessarily predict a price drop.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 3:15 pm

MSTR

MicroStrategy shares are trading higher due to an increase in crypto-related stocks, driven by a surge in Bitcoin's value.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:14 pm

DELL

Dell shares are experiencing an uptick due to a broader rally in technology stocks, which was sparked by Micron's robust earnings report.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:07 pm

RDDT

Reddit's shares are expected to open between $42-$46, significantly higher than the IPO price of $34 each. This indicates strong investor interest and a positive market reception for Reddit's public debut.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:07 pm

ARGX

JNJ

RHHBY

Argenx SE (NASDAQ:ARGX) shares surged due to Chugai Pharmaceutical's disappointing gMG trial results, boosting Argenx's market cap to $21.2 billion. Argenx's Vyvgart Hytrulo was FDA approved in June 2023 for gMG in adults, contributing to $1.2 billion in FY2023 revenues. Chugai's Enspryng failed to meet expectations in its Phase 3 LUMINESCE study for gMG, despite being developed with Roche Holdings AG (OTC:RHHBY). Johnson & Johnson (NYSE:JNJ) reported success in its Phase 3 VIVACITY study of nipocalimab for gMG.

Portfolio Pulse from Vandana Singh

March 21, 2024 | 3:06 pm

LXEH

Trading of Lixiang Education Holding Co. (LXEH) shares has resumed. This follows a temporary suspension, details of which were not provided in the article.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:04 pm

XLMUSD

Stellar's (CRYPTO: XLM) price has seen a 5.67% increase over the past 24 hours to $0.13, despite a 7.0% decrease over the past week. The trading volume has decreased by 28.0%, and the circulating supply has slightly decreased to 57.39% of its max supply. Stellar's current market cap ranking is #35 at $3.81 billion.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 3:03 pm

ATOMUSD

Cosmos Hub's (CRYPTO: ATOM) price increased by 3.92% in the last 24 hours to $11.73, despite a 14.0% decrease over the past week from $13.67. The coin's all-time high is $44.45. Trading volume fell by 6.0% over the past week, while the circulating supply rose by 0.12% to 390.69 million. ATOM's market cap ranks #30 at $4.58 billion.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 3:02 pm

FILUSD

Filecoin (CRYPTO: FIL) saw a price increase of 10.27% in the last 24 hours, reaching $9.11, despite a 13.0% decrease over the past week from $10.28. The coin's all-time high is $236.84. Trading volume decreased by 4.0% over the past week, while circulating supply rose by 0.71% to over 525.93 million, representing 26.82% of its max supply. Filecoin's market cap ranks #27 at $4.78 billion.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 3:02 pm